Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP927505.RAgRdVL3tuFb7gs4cu-FElnHyB3_LYgnmhXgrcXArJd7o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP927505.RAgRdVL3tuFb7gs4cu-FElnHyB3_LYgnmhXgrcXArJd7o130_assertion type Assertion NP927505.RAgRdVL3tuFb7gs4cu-FElnHyB3_LYgnmhXgrcXArJd7o130_head.
- NP927505.RAgRdVL3tuFb7gs4cu-FElnHyB3_LYgnmhXgrcXArJd7o130_assertion description "[Furthermore, CXCL12 expression was restored in gastric cancer cell lines after treatment with the demethylating agent, 5-aza-2'-deoxycytidine (5-Aza-dC), and demethylation of the highly metastatic cells SGC-7901 induced invasion suppression of the cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP927505.RAgRdVL3tuFb7gs4cu-FElnHyB3_LYgnmhXgrcXArJd7o130_provenance.
- NP927505.RAgRdVL3tuFb7gs4cu-FElnHyB3_LYgnmhXgrcXArJd7o130_assertion evidence source_evidence_literature NP927505.RAgRdVL3tuFb7gs4cu-FElnHyB3_LYgnmhXgrcXArJd7o130_provenance.
- NP927505.RAgRdVL3tuFb7gs4cu-FElnHyB3_LYgnmhXgrcXArJd7o130_assertion SIO_000772 21960286 NP927505.RAgRdVL3tuFb7gs4cu-FElnHyB3_LYgnmhXgrcXArJd7o130_provenance.
- NP927505.RAgRdVL3tuFb7gs4cu-FElnHyB3_LYgnmhXgrcXArJd7o130_assertion wasDerivedFrom befree-2016 NP927505.RAgRdVL3tuFb7gs4cu-FElnHyB3_LYgnmhXgrcXArJd7o130_provenance.
- NP927505.RAgRdVL3tuFb7gs4cu-FElnHyB3_LYgnmhXgrcXArJd7o130_assertion wasGeneratedBy ECO_0000203 NP927505.RAgRdVL3tuFb7gs4cu-FElnHyB3_LYgnmhXgrcXArJd7o130_provenance.